SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System

Leading on Studying Short DAPT

Boston Scientific is committed to clinical science that meets what physicians encounter in their everyday practice, including the need for shortened DAPT. We are studying shortened DAPT with SYNERGY Bioabsorbable Polymer (BP) Stent in different patient populations.

 

Supporting Well-Constructed Prospective Short DAPT BP-DES Clinical Trials

SENIOR*

1-month DAPT in stable elderly patients
6-month DAPT in ACS elderly patients
View the SENIOR Trial data  
1,200 Patients
SYNERGY BP-DES vs REBEL™ BMS

EVOLVE Short DAPT

3-month DAPT in HBR patients
2,000 Patients
IDE Trial | SYNERGY BP-DES

IDEAL Left Main*

4-month DAPT in Left Main with SYNERGY BP-DES
12-month DAPT in Left Main with Xience™ PP-DES
818 Patients
Left Main PCI

POEM*

1-month DAPT in HBR patients
1,023 Patients
SYNERGY BP-DES

 
Early Healing

Early Healing

Advanced design for optimal healing

Button
Clinical Outcomes

Clinical Outcomes

Outstanding evidence across trials

Button
Efficiency

Efficiency

How design impacts economic value

Button
Top